Targeted Therapies in Cancer: To Be or Not to Be, Selective

Development of targeted therapies in recent years revealed several nonchemotherapeutic options for patients. Chief among targeted therapies is small molecule kinase inhibitors targeting key oncogenic signaling proteins. Through competitive and noncompetitive inhibition of these kinases, and therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Montoya, Skye, Soong, Deborah, Nguyen, Nina, Affer, Maurizio, Munamarty, Sailasya P., Taylor, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615814/
https://www.ncbi.nlm.nih.gov/pubmed/34829820
http://dx.doi.org/10.3390/biomedicines9111591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615814/
https://www.ncbi.nlm.nih.gov/pubmed/34829820
http://dx.doi.org/10.3390/biomedicines9111591

Ejemplares similares